The investigation of theraputic effect of Bilinaster drop on neonatal hyperbiirubinemia
Phase 2
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecifiedP59.9
- Registration Number
- IRCT2016091828188N3
- Lead Sponsor
- Vice chancellor for research, Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All term neonate with jaundice weighted between 2500 -4000 gr and fed with breast milk
Exclusion Criteria
blood incompatibility or Rh incompatibility
Fauvism
immaturity
need for blood transfusions
hemolysis
infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Baby serum total bilirubin. Timepoint: Every 24 hours for 5 days. Method of measurement: Laboratory test.
- Secondary Outcome Measures
Name Time Method ength of hospitalization days. Timepoint: At the time of discharge. Method of measurement: From the time of admission to discharge.;The incidence of complications arising from the use of Cotoneaster. Timepoint: Every 24 hours for 5 days. Method of measurement: Observation and complete check list.;Evaluation of side effects in case of Cotoneaster. Timepoint: Every 24 hours for 5 days. Method of measurement: Observation and complete check list.;The frequency of defecation. Timepoint: Daily. Method of measurement: Examination.